Do you or someone you know suffer from Chronic Limb-Threatening Ischemia? (CLTI)

Also known as Critical Limb Ischemia (CLI)

Discover a potential treatment option with BioGenCell’s BGC101!


Join Our Trial Today or Refer
a Family Member of a Friend

Learn More About BioGenCell’s
Groundbreaking TRACT Solution 

How Does it Work?

BioGenCell Cell-Therapy Transforms Your Own Blood into Your Personalized Medicine - in 3 Steps!

We harness the incredible power of cell therapy and immunity to provide you with a 3-step treatment:

blood collection

Blood collection





We Know that CLI Leads
to Extreme Suffering

CLI decreases patients’ quality of life and restricts their functionality. BioGenCell is committed to finding a solution that could change this reality.

Our Commitment

BioGenCell’s team works to improve the condition of CLI patients through break-through cell-therapy treatments that are accessible, clinician-friendly and patient-friendly.

Great Benefits for CLI Patients

Our unique and advanced cell therapy methodology is based on immune cells and stem cells and is intended for those suffering from CLI and PAD.

In a rapid, one-time treatment, a patient’s blood is collected and the cells are returned to the patient after a short procedure, with the goal of achieving amputation free 12 months survival.

The Advantages of the BioGenCell Treatment


biogencell trial

Easy to Use

biogencell trial


biogencell trial


biogencell trial

Wide Range
of Conditions

biogencell trial


biogencell trial

Patients Don’t Have to Suffer Anymore!
Success in CLI Patients

BGC101 was found safe in the Hind Limb Ischemia (HLI) preclinical model of CLI.

Quality of Life*

Quality of life

* 6 months results from first, in human, open-labeled study in 5 no-option patients.

We may use cookies to enhance your browsing experience, and analyze usage in the Website.